Roderick O'Connor

14PUBLICATIONS
108CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 22, 2026
Lipids in ovarian cancer ascites impair T cell activation by disrupting TCR dynamics.

|Jun 22, 2026
Fate induction through asymmetric T cell division is modulated by chimeric antigen receptor costimulatory domains.

|Apr 16, 2026
Single-day nonactivated IL-18-armed CAR T cells establish a durable, stemlike state with enhanced persistence.

|Nov 13, 2024
TET2 regulates early and late transitions in exhausted CD8+ T cell differentiation and limits CAR T cell function.

Alexander J Dimitri, Amy E Baxter, Gregory M Chen

|May 20, 2024
The Glucose Transporter 5 Enhances CAR-T Cell Metabolic Function and Anti-tumour Durability.

Bakir Valentić, Andre Kelly, Alexander A Shestov

|Dec 19, 2023
Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokines.

Guido Ghilardi, Luca Paruzzo, Jakub Svoboda

Pageof 3

Frequent Collaborators

3 joint publications

Bakir Valentić

3 joint publications

Carl H June

2 joint publications

Gabriela Plesa

2 joint publications

Chloe Leff